Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM)
2011-01-01 Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Barbato, E; Beretta, Gd; Bravi, S; Caffo, O; Canobbio, L; Carrozza, F; Cinieri, S; Cruciani, G; Dinota, A; Gebbia, V; Giustini, L; Graiff, C; Molino, A; Muggiano, A; Pandoli, G; Puglisi, F; Tagliaferri, P; Tomao, S; Venturini, M
A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer
2011-01-01 Amadori, D; Milandri, C; Comella, G; Saracchini, S; Salvagni, S; Barone, C; Bordonaro, R; Gebbia, V; Barbato, A; Serra, P; Gattuso, D; Nanni, O; Baconnet, B; Gasparini, G.
Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial
2011-01-01 Pignata, Sandro; Scambia, Giovanni; Ferrandina, Gabriella; Savarese, Antonella; Sorio, Roberto; Breda, Enrico; Gebbia, Vittorio; Musso, Pietro; Frigerio, Luigi; Del Medico, Pietro; Lombardi, Alessandra Vernaglia; Febbraro, Antonio; Scollo, Paolo; Ferro, Antonella; Tamberi, Stefano; Brandes, Alba; Ravaioli, Alberto; Valerio, Maria Rosaria; Aitini, Enrico; Natale, Donato; Scaltriti, Laura; Greggi, Stefano; Pisano, Carmela; Lorusso, Domenica; Salutari, Vanda; Legge, Francesco; Di Maio, Massimo; Morabito, Alessandro; Gallo, Ciro; Perrone, Francesco
Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE)
2011-01-01 Galetta, D; Pisconti, S; Cinieri, S; Pappagallo, Gl; Gebbia, V; Borsellino, N; Maiello, E; Rinaldi, A; Montrone, M; Rizzo, P; Marzano, N; Sasso, N; Febbraro, A; Colucci, G.
Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel
2011-01-01 Gebbia, Vittorio; Serretta, Vincenzo; Borsellino, N; Valerio, Maria Rosaria
Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study
2011-01-01 Gridelli, C; Ardizzoni, A; Barni, S; Crinò, L; Caprioli, A; Piazza, E; Lorusso, V; Barbera, S; Zilembo, N; Gebbia, V; Adamo, V; Pela, R; Marangolo, M; Morena, R; Filippelli, G; Buscarino, C; Alabiso, O; Maione, P; Venturino, P; De Marinis, F
A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer
2012-01-01 Grossi, F; de Marinis, F; Gebbia, V; Riccardi, F; Caffo, O; Gamucci, T; Ferraù, F; Nardi, M; Moscetti, L; Boni, L; Dondi, D; Galligioni, E.
Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma
2012-01-01 Gebbia, Vittorio; Boussen, H.; Valerio, Maria Rosaria
Erlotinib versus standard chemotherapy as fi rst-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial
2012-01-01 Rosell, R; Carcereny, E; Gervais, R; Vergnenegre, A; Massuti, B; Felip, E; Palmero, R; Garcia-Gomez, R; Pallares, C; Sanchez, Jm; Porta, R; Cobo, M; Garrido, P; Longo, F; Moran, T; Insa, A; De Marinis, F; Corre, R; Bover, I; Illiano, A; Dansin, E; de Castro, J; Milella, M; Reguart, N; Altavilla, G; Jimenez, U; Provencio, M; Moreno, Ma; Terrasa, J; Muñoz-Langa, J; Valdivia, J; Isla, D; Domine, M; Molinier, O; Mazieres, J; Baize, N; Garcia-Campelo, R; Robinet, G; Rodriguez-Abreu, D; Lopez-Vivanco, G; Gebbia, V; Ferrera-Delgado, L; Bombaron, P; Bernabe, R; Bearz, A; Artal, A; Cortesi, E; Rolfo, C; Sanchez-Ronco, M; Drozdowskyj, A; Queralt, C; de Aguirre, I; Ramirez, Jl; Sanchez, Jj; Molina, Ma; Taron, M; Paz-Ares, L
Spinal analgesia for advanced cancer patients: an update
2011-01-01 Mercadante, S; Porzio, G; Gebbia, V
Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents
2012-01-01 Gebbia, Vittorio; Bellavia, G; Ferraù, F; Valerio, Maria Rosaria
Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials
2012-01-01 Di Maio, M; Signoriello, S; Morabito, A; Rossi, A; Maione, P; Piantedosi, Fv; Bilancia, D; Cigolari, S; Barbera, S; Gebbia, V; Daniele, B; Robbiati, F; Illiano, A; Ceribelli, A; Carrozza, F; Favaretto, A; Piazza, E; Piccirillo, Mc; Daniele, G; Giordano, P; Costanzo, R; Sandomenico, C; Rocco, G; Gallo, C; Perrone, F; Gridelli, C
First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial
2012-01-01 Gridelli, C; Ciardiello, F; Gallo, C; Feld, R; Butts, C; Gebbia, V; Maione, P; Morgillo, F; Genestreti, G; Favaretto, A; Leighl, N; Wierzbicki, R; Cinieri, S; Alam, Y; Siena, S; Tortora, G; Felletti, R; Riccardi, F; Mancuso, G; Rossi, A; Cantile, F; Tsao, Ms; Saieg, M; da Cunha Santos, G; Piccirillo, Mc; Di Maio, M; Morabito, A; Perrone, F.
A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia
2012-01-01 Serretta, Vincenzo; Altieri, V; Morgia, G.; Nicolosi, F.; De Grande, G.; Mazza, R.; Melloni, Darvinio; Allegro, Rosalinda; Ferraù, F.; Gebbia, Vittorio
Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer
2012-01-01 Di Maio, M; Leighl, N; Gallo, C; Feld, R; Ciardiello, F; Butts, C; Maione, P; Gebbia, Vittorio; Morgillo, F; Wierzbicki, R; Favaretto, A; Alam, Y; Cinieri, S; Siena, S; Bianco, R; Riccardi, F; Spatafora, Mario; Ravaioli, A; Felletti, R; Fregoni, V; Genestreti, G; Rossi, A; Mancuso, G; Fasano, M; Morabito, A; Tsao, M; Signoriello, S; Perrone, F; Gridelli, C.
Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM).
2013-01-01 Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Barbato, E; Beretta, Gd; Bravi, S; Caffo, O; Canobbio, L; Carrozza, F; Cinieri, S; Cruciani, G; Dinota, A; Gebbia, V; Giustini, L; Graiff, C; Molino, A; Muggiano, A; Pandoli, G; Puglisi, F; Tagliaferri, P; Tomao, S; Lunardi, G; Venturini, M; AIOM Working Group “Interaction with Regional Sections”, (2009-2011).
Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer
2013-01-01 Gebbia, V; Bellavia, M; Banna, Gl; Russo, P; Ferraù, F; Tralongo, P; Borsellino, N.
Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study.
2013-01-01 Morabito, A; Gebbia, V; Di Maio, M; Cinieri, S; Viganò, Mg; Bianco, R; Barbera, S; Cavanna, L; De Marinis, F; Montesarchio, V; Costanzo, R; Sandomenico, C; Montanino, A; Mancuso, G; Russo, P; Nacci, A; Giordano, P; Daniele, G; Piccirillo, Mc; Rocco, G; Gridelli, C; Gallo, C; Perrone, F.
A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer.
2013-01-01 de Marinis, F; Atmaca, A; Tiseo, M; Giuffreda, L; Rossi, A; Gebbia, V; D'Antonio, C; Dal Zotto, L; Al-Batran, Se; Marsoni, S; Wolf, M.
Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial.
2014-01-01 Butts, C; Socinski, Ma; Mitchell, Pl; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, Te; Bosquée, L; Trigo, Jm; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Wickart-Johansson, G; Ellis, P; Gladkov, O; Pereira, Jr; Eberhardt, We; Helwig, C; Schröder, A; Shepherd FA Shepherd, F; Butts, C; Thatcher, N; Socinski, M; Mitchell, P; Talbot, D; Gillen, D; Whang-Peng, J; Thirwell, M; Seeber, S; Braun, D; Schröder, A; Falk, M; Günther, B; Marschner, Jp; Helwig, C; Loos, A; Tyroller, K; Schüler, A; Ferrande, L; Gaumond, B; Olchowka, K; Koh, P; Mackiewicz, M; Sylvester, E; Wallis, N; Joerg, I; Schick, R; Munn, J; Best, M; Campbell, A; Laszczewska, V; Parvez, T; Ferro, A; Tremblay, L; Sadjadian, P; Smit, E; Park, K; Kotz, K; Borghaei, H; Stehle, I; Ismael, C; Alam, Z; Engel-Riedel, W; Stigt, J; García Girón, C; Kumar, K; Oton, A; Jäger, E; Pasccon, Gv; von Ksienski, D; Pawel, J; van den Borne, B; Trigo, Jm; Lester, E; Nader, D; Kortsik, C; Martin, C; Murray, N; Serke, M; van den Heuvel, M; Vazquez, S; March, R; Li, Z; Wolf, M; Pallotta, M; Macneil, M; Georgoulias, V; van Ojik, H; López Vivanco, G; Masri, M; Espinoza, A; Rüttinger, D; Perazzo, F; Hirsh, V; Kosmidis, P; Krouwels, F; Paredes, A; Shinn, L Jr; Limentani, S; Eschbach, C; Ponce, W; Findlay, B; Pectasides, D; Chmielowska, E; Viñolas, N; Mirtsching, B; Pincus, S; Gahn, B; Fein, L; Burkes, R; Syrigos, K; Jagiello-Gruszfeld, A; Massuti, B; Okazaki, I; Young, D; Kollmeier, J; Zarbá, J; Maccormick, R; Fountzilas, G; Kozielski, J; Gonzalez-Larriba, Jl; Saleh, M; Nugent, F 3rd; Gütz, S; Bella, S; Wang, J; Samantas, E; Krzakowski, M; Barragán, Pl; Curran, C; Chaudhry, A; Wilke, H; Bagnes, C; Sun, Y; Lee, V; Lesniewski-Kmak, K; Alonso, G; Gabrail, N; Ndum, P; Reck, M; Mitchell, P; Koubková, L; Mok, T; Ramlau, R; Bosch, J; Abbott, K; Beall, C; Shepherd, F; Millward, M; Reiterer, P; Albert, I; Rysz-Postawa, B; Moreno, Ma; Bellam, S; Nieva, J; Maksymiuk, A; Boyer, M; Roubec, J; Losonczy, G; Labij, V; de Castro, J; Charu, V; Modi, S; Butts, C; Mccaffrey, E; Salajka, F; Szima, B; Rusinowska, Z; Wichardt-Johansson, G; Erlich, R; Dudek, A; Ellis, P; Pavlakis, N; Havel, L; Zsiray, M; Szczesna, A; Ewers, Sv; Page, R; Ghazal, H; Lee, C; Crombie, C; Zemanová, M; Szabó, P; Freier, B; Henriksson, R; Rao, H; Gitlitz, B; Desjardins, P; Kirsten, F; Hansen, O; Bittner, N; Kus, J; Nyman, J; Sanborn, R; Harrer, G; Vergidis, D; Pirker, R; Ryberg, M; Bittner, N; Sawrycki, P; Nilsson, K; Bruno, D; Mehdi, A; Cohen, V; Kolb, R; Louridi, Jb; Chacko, R; Chojnacka, M; Bergström, S; Shah, S; Jones, C; Bebb, G; Mohn-Staudner, A; Robinet, G; Raja, R; Nawrocki, S; Zippelius, A; Shirinian, M; Gotovkin, E; Soulières, D; Greil, R; Zalcman, G; Julka, Pk; Fijuth, J; Pless, M; Abdel Karim, I; Soo, R; Thropay, J; Hilbe, W; Choma, D; Digumarti, R; Barata, Fj; Mach, N; Neerukonda, L; Kasan, P; Akunyili, I; Kropfmüller, R; Verkindre, C; Advani, S; Teixeira, E; Yang, Ch; Bonomi, P; Packan, T; Argiris, A; Samonigg, H; Dumont, P; Vamsy, M; Almodovar, Mt; Liu, Mc; Rakkar, A; Berzinec, P; Edelman, M; Vansteenkiste, J; Tourani, Jm; O'Byrne, K; Araújo, A; Hsia, Tc; Rao, R; Kang, Jh; Natale, R; Lambrechts, M; Gervais, R; Cyjon, A; Dediu, M; Chang, Gc; Dowlati, A; Kim, Sw; Ottensmeier, C; Humblet, Y; Schott, R; Dudnik, J; Anghel, R; Chen, Ym; Weiss, J; Lee, Js; Collinson, M; Duplaquet, F; Spaeth, D; Gottfried, M; Ciuleanu, Td; Tsao, Ch; Spira, A; Kim, Jh; Thomas, G; Louis, R; Barlesi, F; Merimsky, O; Volovat, C; Kuo, Hp; Langer, C; Heo, Ds; O'Brien, M; Clinckart, F; Fabre-Guillevin, E; Peylan-Ramu, N; Ganea Motan, De; Huang, Ms; Vrindavanam, N; Gebbia, V; Macgregor, C; Verhoeven, D; Pibarot, M; Sulkes, A; Patran, M; Su, Wc; Bhanja, U; Ciardiello, F; Tjulandin, S; de Azevedo, S; Westeel, V; Wollner, M; Sirbu, D; Lin, Mc; Hoffman, S; Grossi, F; Popov, V; Barrios, Ch; Mornex, F; Onn, A; Cheporov, S; Price, A; Bednar, M; Aglietta, M; Goldberg, V; Delgado, G; Thomas, M; Platania, M; Gladkov, O; Snee, M; Bhaskar, B; Contu, A; Medvedev, V; Franke, Fa; Waller, C; Siena, C; Mikhaylov, S; Dorey, N; Caputto, S; Gridelli, C; Khasanov, R; Malzyner, A; Eberhardt, W; Amadori, D; Lubennikov, V; Marshall, E; Chen, Lc; Guevara Torres, A; Santoro, A; Nugué, P; Schneller, F; De Marinis, F; Akhmadullina, L; Ezhil, M; West, H; Trigueros Velázquez, M; Scagliotti, G; Pizão, ; Griesinger, F; Longo, L; Byakhov, M; Hicks, J; Berg, A; Ramírez Márquez, M; Tiseo, M; Segalla, ; Hildebrandt, G; Martoni, A; Moiseyenko, V; Taylor, P; Hays, J; Arrieta Rodriguez, Og; Caffo, O; Mathias, Cm; Huber, R; Witt, C; Murad, A; Höffken, G; Gorini, C; Zukin, M; Iacobelli, S; Pereira, J; Schreiber, J; Wehler, T.
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Disparity in the "time to patient access" to new anti-cancer drugs in Italian regions. Results of a survey conducted by the Italian Society of Medical Oncology (AIOM) | 1-gen-2011 | Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Barbato, E; Beretta, Gd; Bravi, S; Caffo, O; Canobbio, L; Carrozza, F; Cinieri, S; Cruciani, G; Dinota, A; Gebbia, V; Giustini, L; Graiff, C; Molino, A; Muggiano, A; Pandoli, G; Puglisi, F; Tagliaferri, P; Tomao, S; Venturini, M | |
| A phase I/II trial of non-pegylated liposomal doxorubicin, docetaxel and trastuzumab as first-line treatment in HER-2-positive locally advanced or metastatic breast cancer | 1-gen-2011 | Amadori, D; Milandri, C; Comella, G; Saracchini, S; Salvagni, S; Barone, C; Bordonaro, R; Gebbia, V; Barbato, A; Serra, P; Gattuso, D; Nanni, O; Baconnet, B; Gasparini, G. | |
| Carboplatin Plus Paclitaxel Versus Carboplatin Plus Pegylated Liposomal Doxorubicin As First-Line Treatment for Patients With Ovarian Cancer: The MITO-2 Randomized Phase III Trial | 1-gen-2011 | Pignata, Sandro; Scambia, Giovanni; Ferrandina, Gabriella; Savarese, Antonella; Sorio, Roberto; Breda, Enrico; Gebbia, Vittorio; Musso, Pietro; Frigerio, Luigi; Del Medico, Pietro; Lombardi, Alessandra Vernaglia; Febbraro, Antonio; Scollo, Paolo; Ferro, Antonella; Tamberi, Stefano; Brandes, Alba; Ravaioli, Alberto; Valerio, Maria Rosaria; Aitini, Enrico; Natale, Donato; Scaltriti, Laura; Greggi, Stefano; Pisano, Carmela; Lorusso, Domenica; Salutari, Vanda; Legge, Francesco; Di Maio, Massimo; Morabito, Alessandro; Gallo, Ciro; Perrone, Francesco | |
| Induction pemetrexed and cisplatin followed by maintenance pemetrexed versus carboplatin plus paclitaxel plus bevacizumab followed by maintenance bevacizumab: a quality of life-oriented randomized phase III study in patients with advanced non-squamous non-small-cell lung cancer (ERACLE) | 1-gen-2011 | Galetta, D; Pisconti, S; Cinieri, S; Pappagallo, Gl; Gebbia, V; Borsellino, N; Maiello, E; Rinaldi, A; Montrone, M; Rizzo, P; Marzano, N; Sasso, N; Febbraro, A; Colucci, G. | |
| Salvage Therapy With Oral Metronomic Cyclophosphamide and Methotrexate for Castration refractory Metastatic Adenocarcinoma of the Prostate Resistant to Docetaxel | 1-gen-2011 | Gebbia, Vittorio; Serretta, Vincenzo; Borsellino, N; Valerio, Maria Rosaria | |
| Medical treatment choices for patients affected by advanced NSCLC in routine clinical practice: results from the Italian observational "SUN" (Survey on the lUng cancer maNagement) study | 1-gen-2011 | Gridelli, C; Ardizzoni, A; Barni, S; Crinò, L; Caprioli, A; Piazza, E; Lorusso, V; Barbera, S; Zilembo, N; Gebbia, V; Adamo, V; Pela, R; Marangolo, M; Morena, R; Filippelli, G; Buscarino, C; Alabiso, O; Maione, P; Venturino, P; De Marinis, F | |
| A randomised phase II trial of two sequential schedules of docetaxel and cisplatin followed by gemcitabine in patients with advanced non-small-cell lung cancer | 1-gen-2012 | Grossi, F; de Marinis, F; Gebbia, V; Riccardi, F; Caffo, O; Gamucci, T; Ferraù, F; Nardi, M; Moscetti, L; Boni, L; Dondi, D; Galligioni, E. | |
| Oral metronomic cyclophosphamide with and without methotrexate as palliative treatment for patients with metastatic breast carcinoma | 1-gen-2012 | Gebbia, Vittorio; Boussen, H.; Valerio, Maria Rosaria | |
| Erlotinib versus standard chemotherapy as fi rst-line treatment for European patients with advanced EGFR mutation-positive non-small-cell lung cancer (EURTAC): a multicentre, open-label, randomised phase 3 trial | 1-gen-2012 | Rosell, R; Carcereny, E; Gervais, R; Vergnenegre, A; Massuti, B; Felip, E; Palmero, R; Garcia-Gomez, R; Pallares, C; Sanchez, Jm; Porta, R; Cobo, M; Garrido, P; Longo, F; Moran, T; Insa, A; De Marinis, F; Corre, R; Bover, I; Illiano, A; Dansin, E; de Castro, J; Milella, M; Reguart, N; Altavilla, G; Jimenez, U; Provencio, M; Moreno, Ma; Terrasa, J; Muñoz-Langa, J; Valdivia, J; Isla, D; Domine, M; Molinier, O; Mazieres, J; Baize, N; Garcia-Campelo, R; Robinet, G; Rodriguez-Abreu, D; Lopez-Vivanco, G; Gebbia, V; Ferrera-Delgado, L; Bombaron, P; Bernabe, R; Bearz, A; Artal, A; Cortesi, E; Rolfo, C; Sanchez-Ronco, M; Drozdowskyj, A; Queralt, C; de Aguirre, I; Ramirez, Jl; Sanchez, Jj; Molina, Ma; Taron, M; Paz-Ares, L | |
| Spinal analgesia for advanced cancer patients: an update | 1-gen-2011 | Mercadante, S; Porzio, G; Gebbia, V | |
| Adherence, compliance and persistence to oral antineoplastic therapy: A review focused on chemotherapeutic and biologic agents | 1-gen-2012 | Gebbia, Vittorio; Bellavia, G; Ferraù, F; Valerio, Maria Rosaria | |
| Prognostic impact of education level of patients with advanced non-small cell lung cancer enrolled in clinical trials | 1-gen-2012 | Di Maio, M; Signoriello, S; Morabito, A; Rossi, A; Maione, P; Piantedosi, Fv; Bilancia, D; Cigolari, S; Barbera, S; Gebbia, V; Daniele, B; Robbiati, F; Illiano, A; Ceribelli, A; Carrozza, F; Favaretto, A; Piazza, E; Piccirillo, Mc; Daniele, G; Giordano, P; Costanzo, R; Sandomenico, C; Rocco, G; Gallo, C; Perrone, F; Gridelli, C | |
| First-line erlotinib followed by second-line cisplatin-gemcitabine chemotherapy in advanced non-small-cell lung cancer: the TORCH randomized trial | 1-gen-2012 | Gridelli, C; Ciardiello, F; Gallo, C; Feld, R; Butts, C; Gebbia, V; Maione, P; Morgillo, F; Genestreti, G; Favaretto, A; Leighl, N; Wierzbicki, R; Cinieri, S; Alam, Y; Siena, S; Tortora, G; Felletti, R; Riccardi, F; Mancuso, G; Rossi, A; Cantile, F; Tsao, Ms; Saieg, M; da Cunha Santos, G; Piccirillo, Mc; Di Maio, M; Morabito, A; Perrone, F. | |
| A randomized trial comparing tamoxifen therapy vs. tamoxifen prophylaxis in bicalutamide-induced gynecomastia | 1-gen-2012 | Serretta, Vincenzo; Altieri, V; Morgia, G.; Nicolosi, F.; De Grande, G.; Mazza, R.; Melloni, Darvinio; Allegro, Rosalinda; Ferraù, F.; Gebbia, Vittorio | |
| Quality of life analysis of TORCH, a randomized trial testing first-line erlotinib followed by second-line cisplatin/gemcitabine chemotherapy in advanced non-small-cell lung cancer | 1-gen-2012 | Di Maio, M; Leighl, N; Gallo, C; Feld, R; Ciardiello, F; Butts, C; Maione, P; Gebbia, Vittorio; Morgillo, F; Wierzbicki, R; Favaretto, A; Alam, Y; Cinieri, S; Siena, S; Bianco, R; Riccardi, F; Spatafora, Mario; Ravaioli, A; Felletti, R; Fregoni, V; Genestreti, G; Rossi, A; Mancuso, G; Fasano, M; Morabito, A; Tsao, M; Signoriello, S; Perrone, F; Gridelli, C. | |
| Impact of use of oral anticancer drugs on activity of Italian oncology practices: results of a survey conducted by the Italian Society of Medical Oncology (AIOM). | 1-gen-2013 | Gori, S; Di Maio, M; Pinto, C; Alabiso, O; Baldini, E; Barbato, E; Beretta, Gd; Bravi, S; Caffo, O; Canobbio, L; Carrozza, F; Cinieri, S; Cruciani, G; Dinota, A; Gebbia, V; Giustini, L; Graiff, C; Molino, A; Muggiano, A; Pandoli, G; Puglisi, F; Tagliaferri, P; Tomao, S; Lunardi, G; Venturini, M; AIOM Working Group “Interaction with Regional Sections”, (2009-2011). | |
| Treatment monitoring program for implementation of adherence to second-line erlotinib for advanced non-small-cell lung cancer | 1-gen-2013 | Gebbia, V; Bellavia, M; Banna, Gl; Russo, P; Ferraù, F; Tralongo, P; Borsellino, N. | |
| Randomized phase III trial of gemcitabine and cisplatin vs. gemcitabine alone in patients with advanced non-small cell lung cancer and a performance status of 2: the CAPPA-2 study. | 1-gen-2013 | Morabito, A; Gebbia, V; Di Maio, M; Cinieri, S; Viganò, Mg; Bianco, R; Barbera, S; Cavanna, L; De Marinis, F; Montesarchio, V; Costanzo, R; Sandomenico, C; Montanino, A; Mancuso, G; Russo, P; Nacci, A; Giordano, P; Daniele, G; Piccirillo, Mc; Rocco, G; Gridelli, C; Gallo, C; Perrone, F. | |
| A phase II study of the histone deacetylase inhibitor panobinostat (LBH589) in pretreated patients with small-cell lung cancer. | 1-gen-2013 | de Marinis, F; Atmaca, A; Tiseo, M; Giuffreda, L; Rossi, A; Gebbia, V; D'Antonio, C; Dal Zotto, L; Al-Batran, Se; Marsoni, S; Wolf, M. | |
| Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial. | 1-gen-2014 | Butts, C; Socinski, Ma; Mitchell, Pl; Thatcher, N; Havel, L; Krzakowski, M; Nawrocki, S; Ciuleanu, Te; Bosquée, L; Trigo, Jm; Spira, A; Tremblay, L; Nyman, J; Ramlau, R; Wickart-Johansson, G; Ellis, P; Gladkov, O; Pereira, Jr; Eberhardt, We; Helwig, C; Schröder, A; Shepherd FA Shepherd, F; Butts, C; Thatcher, N; Socinski, M; Mitchell, P; Talbot, D; Gillen, D; Whang-Peng, J; Thirwell, M; Seeber, S; Braun, D; Schröder, A; Falk, M; Günther, B; Marschner, Jp; Helwig, C; Loos, A; Tyroller, K; Schüler, A; Ferrande, L; Gaumond, B; Olchowka, K; Koh, P; Mackiewicz, M; Sylvester, E; Wallis, N; Joerg, I; Schick, R; Munn, J; Best, M; Campbell, A; Laszczewska, V; Parvez, T; Ferro, A; Tremblay, L; Sadjadian, P; Smit, E; Park, K; Kotz, K; Borghaei, H; Stehle, I; Ismael, C; Alam, Z; Engel-Riedel, W; Stigt, J; García Girón, C; Kumar, K; Oton, A; Jäger, E; Pasccon, Gv; von Ksienski, D; Pawel, J; van den Borne, B; Trigo, Jm; Lester, E; Nader, D; Kortsik, C; Martin, C; Murray, N; Serke, M; van den Heuvel, M; Vazquez, S; March, R; Li, Z; Wolf, M; Pallotta, M; Macneil, M; Georgoulias, V; van Ojik, H; López Vivanco, G; Masri, M; Espinoza, A; Rüttinger, D; Perazzo, F; Hirsh, V; Kosmidis, P; Krouwels, F; Paredes, A; Shinn, L Jr; Limentani, S; Eschbach, C; Ponce, W; Findlay, B; Pectasides, D; Chmielowska, E; Viñolas, N; Mirtsching, B; Pincus, S; Gahn, B; Fein, L; Burkes, R; Syrigos, K; Jagiello-Gruszfeld, A; Massuti, B; Okazaki, I; Young, D; Kollmeier, J; Zarbá, J; Maccormick, R; Fountzilas, G; Kozielski, J; Gonzalez-Larriba, Jl; Saleh, M; Nugent, F 3rd; Gütz, S; Bella, S; Wang, J; Samantas, E; Krzakowski, M; Barragán, Pl; Curran, C; Chaudhry, A; Wilke, H; Bagnes, C; Sun, Y; Lee, V; Lesniewski-Kmak, K; Alonso, G; Gabrail, N; Ndum, P; Reck, M; Mitchell, P; Koubková, L; Mok, T; Ramlau, R; Bosch, J; Abbott, K; Beall, C; Shepherd, F; Millward, M; Reiterer, P; Albert, I; Rysz-Postawa, B; Moreno, Ma; Bellam, S; Nieva, J; Maksymiuk, A; Boyer, M; Roubec, J; Losonczy, G; Labij, V; de Castro, J; Charu, V; Modi, S; Butts, C; Mccaffrey, E; Salajka, F; Szima, B; Rusinowska, Z; Wichardt-Johansson, G; Erlich, R; Dudek, A; Ellis, P; Pavlakis, N; Havel, L; Zsiray, M; Szczesna, A; Ewers, Sv; Page, R; Ghazal, H; Lee, C; Crombie, C; Zemanová, M; Szabó, P; Freier, B; Henriksson, R; Rao, H; Gitlitz, B; Desjardins, P; Kirsten, F; Hansen, O; Bittner, N; Kus, J; Nyman, J; Sanborn, R; Harrer, G; Vergidis, D; Pirker, R; Ryberg, M; Bittner, N; Sawrycki, P; Nilsson, K; Bruno, D; Mehdi, A; Cohen, V; Kolb, R; Louridi, Jb; Chacko, R; Chojnacka, M; Bergström, S; Shah, S; Jones, C; Bebb, G; Mohn-Staudner, A; Robinet, G; Raja, R; Nawrocki, S; Zippelius, A; Shirinian, M; Gotovkin, E; Soulières, D; Greil, R; Zalcman, G; Julka, Pk; Fijuth, J; Pless, M; Abdel Karim, I; Soo, R; Thropay, J; Hilbe, W; Choma, D; Digumarti, R; Barata, Fj; Mach, N; Neerukonda, L; Kasan, P; Akunyili, I; Kropfmüller, R; Verkindre, C; Advani, S; Teixeira, E; Yang, Ch; Bonomi, P; Packan, T; Argiris, A; Samonigg, H; Dumont, P; Vamsy, M; Almodovar, Mt; Liu, Mc; Rakkar, A; Berzinec, P; Edelman, M; Vansteenkiste, J; Tourani, Jm; O'Byrne, K; Araújo, A; Hsia, Tc; Rao, R; Kang, Jh; Natale, R; Lambrechts, M; Gervais, R; Cyjon, A; Dediu, M; Chang, Gc; Dowlati, A; Kim, Sw; Ottensmeier, C; Humblet, Y; Schott, R; Dudnik, J; Anghel, R; Chen, Ym; Weiss, J; Lee, Js; Collinson, M; Duplaquet, F; Spaeth, D; Gottfried, M; Ciuleanu, Td; Tsao, Ch; Spira, A; Kim, Jh; Thomas, G; Louis, R; Barlesi, F; Merimsky, O; Volovat, C; Kuo, Hp; Langer, C; Heo, Ds; O'Brien, M; Clinckart, F; Fabre-Guillevin, E; Peylan-Ramu, N; Ganea Motan, De; Huang, Ms; Vrindavanam, N; Gebbia, V; Macgregor, C; Verhoeven, D; Pibarot, M; Sulkes, A; Patran, M; Su, Wc; Bhanja, U; Ciardiello, F; Tjulandin, S; de Azevedo, S; Westeel, V; Wollner, M; Sirbu, D; Lin, Mc; Hoffman, S; Grossi, F; Popov, V; Barrios, Ch; Mornex, F; Onn, A; Cheporov, S; Price, A; Bednar, M; Aglietta, M; Goldberg, V; Delgado, G; Thomas, M; Platania, M; Gladkov, O; Snee, M; Bhaskar, B; Contu, A; Medvedev, V; Franke, Fa; Waller, C; Siena, C; Mikhaylov, S; Dorey, N; Caputto, S; Gridelli, C; Khasanov, R; Malzyner, A; Eberhardt, W; Amadori, D; Lubennikov, V; Marshall, E; Chen, Lc; Guevara Torres, A; Santoro, A; Nugué, P; Schneller, F; De Marinis, F; Akhmadullina, L; Ezhil, M; West, H; Trigueros Velázquez, M; Scagliotti, G; Pizão, ; Griesinger, F; Longo, L; Byakhov, M; Hicks, J; Berg, A; Ramírez Márquez, M; Tiseo, M; Segalla, ; Hildebrandt, G; Martoni, A; Moiseyenko, V; Taylor, P; Hays, J; Arrieta Rodriguez, Og; Caffo, O; Mathias, Cm; Huber, R; Witt, C; Murad, A; Höffken, G; Gorini, C; Zukin, M; Iacobelli, S; Pereira, J; Schreiber, J; Wehler, T. |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15364
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20267035
- 2010 - 20195807
- 2000 - 20091967
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...225
- JOURNAL OF CLINICAL MEDICINE153
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS77
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY72
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19257
- Humans250
- Female133
- Male127
- SARS-CoV-2108
- inflammation103
- oxidative stress85
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10818
- ita2587
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15367